NCT00517842View on ClinicalTrials.gov

A Triple-blinded, Randomised, Placebo-controlled Trial to Examine the Efficacy and Safety of ViNeuro in Patients With Parkinson's Disease

NACompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

September 30, 2008

Conditions

Parkinson Disease

Interventions

DRUG

ViNeuro

Trial Locations (5)

Unknown

Prince of Wales Hospital, Hong Kong

Princess Margaret Hospital, Hong Kong

Queen Elizabeth Hospital, Hong Kong

Tseung Kwan O Hospital, Hong Kong

United Christian Hospital, Hong Kong

All Listed Sponsors

collaborator

Vigconic (International) Ltd.

INDUSTRY

lead

Hospital Authority, Hong Kong

OTHER_GOV

NCT00517842 - A Triple-blinded, Randomised, Placebo-controlled Trial to Examine the Efficacy and Safety of ViNeuro in Patients With Parkinson's Disease | Biotech Hunter | Biotech Hunter